OPGN
- OpGen, Inc.
()
Overview
Company Summary
OpGen, Inc. is a company that specializes in genomics and bioinformatics solutions. They aim to provide accurate and actionable information for combating infectious diseases, optimizing patient outcomes, and advancing public health.
OpGen primarily focuses on developing and commercializing molecular information products and services that help healthcare professionals in the diagnosis, treatment, and prevention of various infections. They use a combination of genome sequencing, bioinformatics, and data analytics to identify and detect pathogens, assess antibiotic resistance, and provide insights to guide treatment decisions.
The company's flagship product is Acuitas Lighthouse, a cloud-based platform that integrates genetic information from pathogens with patient data to assist in identifying healthcare-associated infections (HAIs) and enabling infection control measures. It enables hospitals and healthcare facilities to track, monitor, and manage HAIs more effectively, improving patient outcomes and reducing healthcare costs.
Additionally, OpGen offers a range of genetic analysis products and services that aid in the early detection, characterization, and tracking of bacterial pathogens. Their Acuitas AMR Gene Panel and Acuitas Rapid Test are used to identify antibiotic-resistant pathogens and guide appropriate antibiotic therapies.
OpGen also collaborates with various partners, including pharmaceutical and diagnostic companies, to develop innovative solutions and enhance their product offerings. With a focus on precision medicine and infectious disease management, OpGen plays a crucial role in the fight against antibiotic resistance and the optimization of patient care.